Reference : Adherence to treatment of osteoporosis: a need for study
Scientific journals : Article
Human health sciences : Endocrinology, metabolism & nutrition
http://hdl.handle.net/2268/18027
Adherence to treatment of osteoporosis: a need for study
English
Lekkerkerker, F. [> > > >]
Kanis, J. A. [> > > >]
Alsayed, N. [> > > >]
Bouvenot, G. [> > > >]
Burlet, N. [> > > >]
Cahall, David [> > > >]
Chines, A. [> > > >]
Delmas, P. [> > > >]
Dreiser, R. L. [> > > >]
Ethgen, Dominique [> >]
Hughes, N. [> > > >]
Kaufman, J. M. [> > > >]
Korte, S. [> > > >]
Kreutz, G. [> > > >]
Laslop, A. [> > > >]
Mitlak, B. [> > > >]
Rabenda, Véronique mailto [Université de Liège - ULg > Département des sciences de la santé publique > Epidémiologie et santé publique >]
Rizzoli, R. [> > > >]
Santora, A. [> > > >]
Schimmer, R. [> > > >]
Tsouderos, Y. [> >]
Viethel, P. [> > > >]
Reginster, Jean-Yves mailto [Université de Liège - ULg > Département des sciences de la santé publique > Epidémiologie et santé publique >]
Oct-2007
Osteoporosis International
Springer London Ltd
18
10
1311-1317
Yes (verified by ORBi)
International
0937-941X
Artington
[en] adherence ; compliance ; persistence ; registration ; reimbursement
[en] Adherence to anti-osteoporosis medications is currently low and is associated with poor anti-fracture efficacy. This manuscript reviews the potential design of clinical studies that aim to demonstrate improved adherence, with new chemical entities to be used in the management of osteoporosis. Introduction Several medications have been unequivocally shown to decrease fracture rates in clinical trials. However, in real life settings, long-term persistence and compliance to anti-osteoporosis medication is poor, hence decreasing the clinical benefits for patients. Methods An extensive search of Medline from 1985 to 2006 retrieved all trials including the keywords osteoporosis, compliance, persistence or adherence followed by a critical appraisal of the data obtained through a consensus expert meeting. Results The impact of non-adherence on the clinical development of interventions is reviewed, so that clinicians, regulatory agencies and reimbursement agencies might be better informed of the problem, in order to stimulate the necessary research to document adherence. Conclusion Adherence to therapy is a major problem in the treatment of osteoporosis. Both patients and medication factors are involved. Adherence studies are an important aspect of outcomes studies, but study methodologies are not well developed at the moment and should be improved. Performing adherence studies will be stimulated when registration authorities accept the result of these studies and include the relevant information in Sect. 5.1 of the summary of product characteristics. Reimbursement authorities might also consider such studies as important information for decisions on reimbursement.
http://hdl.handle.net/2268/18027

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Adherence to treatment of osteoporosis.pdfNo commentaryPublisher postprint141.4 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.